Community-Based Outreach for People Living With Methamphetamine-Associated Cardiomyopathy
Joey Chiang1, Jaimie Pechan2, Kate Smith2
1Department of Medicine, University of Washington, Seattle, Washington, USA.
JACC. Case Reports
|November 1, 2024
Summary
Methamphetamine-associated cardiomyopathy is increasing. A community heart failure program and alarmed pill containers improved patient outcomes and medication adherence.
Area of Science:
- Cardiology
- Toxicology
- Public Health
Background:
- Methamphetamine-associated cardiomyopathy (MACM) is a growing concern in the United States.
- Guideline-directed medical therapy (GDMT) and cessation of methamphetamine use are crucial for managing MACM.
- Barriers to GDMT adherence are common in patients with MACM.
Observation:
- This case series examined patients with MACM.
- Patients engaged in a community heart failure program.
- Alarmed pill containers were utilized to improve medication adherence.
Findings:
- Patients showed significant clinical improvement.
- Echocardiographic measures demonstrated profound recovery.
- The intervention successfully targeted medication adherence.
Implications:
- Community heart failure programs can enhance GDMT delivery for MACM patients.
- Technological aids like alarmed pill containers may overcome adherence barriers.
- This approach offers a promising strategy for improving outcomes in MACM.
Related Concept Videos
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
01:22Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
01:26Heart Failure Drugs: Inotropic Agents
525
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
525
01:27Myocarditis II: Clinical features and Diagnostic Tests
2
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
01:21Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391